A study of sarcopenia in patients with type 2 diabetes mellitus of more than 10 years duration and its association with bone mineral density
- 6 August 2025
- journal article
- research article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-5
Abstract
Introduction Diabetes mellitus is a growing global health concern, with an estimated 643 million individuals projected to be affected by 2030. Sarcopenia, once considered a normal part of aging, is now known to be associated with chronic diseases, including type 2 diabetes mellitus (T2DM). Muscle mass typically declines by approximately 8% per decade after age 40, accelerating to 15–25% per decade after age 70. Aim To determine the prevalence of sarcopenia in patients with T2DM of more than 10 years’ duration and evaluate its association with bone mineral density (BMD). Methods An observational study was conducted at a tertiary care hospital in Salem from January to October 2024. A total of 120 patients with T2DM for over 10 years were included. Data collected included demographics, medical history (fractures, comorbidities, use of insulin, bisphosphonates, or vitamin D supplements), and physical examination findings (weight, height, BMI, and blood pressure). Sarcopenia and BMD were assessed using dual-energy X-ray absorptiometry (DEXA). Results The mean age of participants was 63.4 ± 8.7 years. Most had diabetes for 10–15 years (56.7%), and 32.5% had 16–20 years. The mean BMI was 25.7 ± 3.4 kg/m2. Sarcopenia was present in 30.0% of participants. Additionally, 48.3% had osteopenia and 28.3% had osteoporosis. Conclusion Routine screening for sarcopenia and BMD in older adults with long-standing T2DM is essential for early intervention. Good glycemic control may help mitigate the risk of sarcopenia and related complications.Keywords
This publication has 13 references indexed in Scilit:
- Prevalence of sarcopenia and its determinants in people with type 2 diabetes: Experience from a tertiary care hospital in north IndiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2023
- Decreased handgrip strength in patients with type 2 diabetes: A cross-sectional study in a tertiary care hospital in north IndiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and TreatmentJournal of the American Medical Directors Association, 2020
- Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetesJournal of Diabetes Investigation, 2019
- Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) CodeJournal of the American Medical Directors Association, 2016
- Where frailty meets diabetesDiabetes/Metabolism Research and Reviews, 2016
- Sarcopenia: a predictor of mortality and the need for early diagnosis and interventionAging Clinical and Experimental Research, 2014
- Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014Journal of Cachexia, Sarcopenia and Muscle, 2014
- Sarcopenia: Definition, Epidemiology, and PathophysiologyJournal of Bone Metabolism, 2013
- The Loss of Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and Body Composition StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2006